Jon Kuwahara | executive |
David-Alexandre Gros | executive |
Steven Perrin | executive |
Paul Little | executive |
Alethia Young | analyst |
Rami Katkhuda | analyst |
Thomas Smith | analyst |
Matthew Kaplan | analyst |
Vernon Bernardino | analyst |
Greetings, and welcome to the Eledon Pharmaceuticals' Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Jon Kuwahara, SVP of Finance. Please go ahead, sir.